Prof. Michel Delforge

 

 

Michel Delforge University of Leuven, Leuven, Belgium

Michel Delforge, MD, PhD, is professor of medicine in the department of hematology at the University of Leuven, in Leuven, Belgium. He studied medicine at the University of Leuven, where he obtained a doctoral degree in biomedical sciences. He continued his medical training as a research fellow at the University of Minnesota, Minneapolis, MN, USA, and subsequently undertook a clinical fellowship at the University of Leuven, with specific interests in myelodysplastic syndromes and plasma cell diseases.

Professor Delforge is clinical head of the department of hematology at the University Hospital Leuven. He directs the plasma cell dyscrasia unit with major focus on clinical trials with novel agents and with a specific interest in novel therapies and supportive care. He is the current chair of the myeloma committee of the Belgian Hematology Society and a senior clinical investigator and holds the Fraiture chair in hematology. From 2017 till 2025 he was the director of the Leuven Cancer Institute.

He has authored and co-authored more than 250 articles in peer-reviewed medical journals and several book chapters in the field of hematology